Related Experiment Video
Updated: Jun 20, 2026
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
New approaches in peptide antibiotics.
1Northern Antibiotics Ltd, Eskolantie 1, POB 72, FI-00720 Helsinki, Finland. martti.vaara@northernantibiotics.com
Current Opinion in Pharmacology
|September 8, 2009
Summary
Developing novel antibacterial agents is crucial due to rising antimicrobial resistance. Host-derived antimicrobial peptides (AMPs) show limited success, prompting exploration of bacterial peptides and peptidomimetics for better efficacy.
Area of Science:
- Microbiology
- Pharmacology
- Drug Discovery
Background:
- The rise of extremely multiresistant bacteria necessitates novel antibacterial agents.
- Existing host-derived antimicrobial peptides (AMPs) like pexiganan, omiganan, and iseganan have shown limited clinical success over a decade.
- Novel AMP derivatives often exhibit weak activity, cytotoxicity, and proteolysis susceptibility, with few undergoing rigorous testing.
Purpose of the Study:
- To review the limitations of current host-derived antimicrobial peptides (AMPs).
- To explore alternative antibacterial strategies, focusing on bacterial peptides and peptidomimetics.
- To identify more promising candidates for combating multidrug-resistant bacteria.
Main Methods:
- Literature review of existing and emerging antibacterial agents.
- Analysis of the efficacy and toxicity profiles of various antimicrobial peptide classes.
- Comparative assessment of host-derived AMPs versus bacterial peptides and peptidomimetics.
Main Results:
- Host-derived AMPs have demonstrated insufficient efficacy against multidrug-resistant bacteria.
- Many novel AMP derivatives face challenges including poor activity, off-target toxicity, and degradation.
- Bacterial peptides (e.g., lantibiotics, RTA-3, polymyxins) and peptidomimetics (e.g., ceragenins) show potential.
Conclusions:
- Host-derived AMPs are not currently meeting the need for effective treatments against highly resistant bacteria.
- Bacterial-derived peptides and synthetic peptidomimetics represent more promising avenues for novel antibacterial drug development.
- Further research into bacterial peptides and peptidomimetics is warranted to address the urgent threat of antimicrobial resistance.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
02:43Peptide Bonds
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:28Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...